<DOC>
	<DOCNO>NCT01633242</DOCNO>
	<brief_summary>Background : - Muscular dystrophy affect muscle use heart function breathing . Treatment usually involve drug help improve heart function . However , good type heart image study need improve treatment heart problem related muscular dystrophy . Better heart image method especially need child muscular dystrophy . Researchers want test different heart image method child muscular dystrophy . They look cardiac magnetic resonance imaging ( MRI ) standard heart function test . Objectives : - To develop test new method image heart child muscular dystrophy . Eligibility : - Children adolescents 8 17 year age muscular dystrophy . Design : - Participants screen physical exam medical history . - Participants provide blood sample start study . They also heart function test image study . - Participants cardiac MRI scan last 60 minute . Some test require MRI contrast agent ( drug help image appear clearly scan ) .</brief_summary>
	<brief_title>Heart Imaging Children With Muscular Dystrophy</brief_title>
	<detailed_description>Cardiomyopathy cause significant morbidity mortality multiple form muscular dystrophy affect child , include Duchenne muscular dystrophy ( DMD ) , Becker muscular dystrophy ( BMD ) subtypes autosomal recessive limb-girdle muscular dystrophy ( LGMD2 ) . Pharmaceutical treatment cardiomyopathy muscular dystrophy , include angiotensin-converting enzyme ( ACE ) inhibition beta-adrenergic receptor blockade , afford significant benefit demonstrate cardiac remodel clinical study . Further study need identify characterize sensitive indicator cardiac dysfunction muscular dystrophy subject well stratify subject entry clinical protocol . Using framework Cooperative International Neuromuscular Research Group ( CINRG ) Clinical Translational Science Award ( CTSA ) consortium , pilot study assess cardiac outcome measure child obtain gadolinium enhance cardiac Magnetic Resonance Imaging ( MRI ) echocardiographic method reliably implement across consortium clinical site devote study pharmaceutical treatment muscular dystrophy . These cardiac MRI scan share PITT1109 research protocol subject enrolled study .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<criteria>INCLUSION CRITERIA : Male female diagnosis Duchenne , Becker , Limb Girdle Muscular Dystrophy . 8 100 year age . EXCLUSION CRITERIA : Daytime user continuous positive airway pressure ( CPAP ) Sip ventilator user Invasive ventilator dependent Pregnant minor ( uncertain , participant undergo urine test ) lactate minor Decompensated congestive heart failure ( unable lie flat CMR ) Impaired renal excretory function ( calculated Glomerular Filtration Rate le 30mL/min ) Contraindications Magnetic Resonance Imaging : Cardiac pacemaker implantable defibrillator Cerebral aneurysm clip Neural stimulator Metallic ocular foreign body Harringtonrod Any implanted device ( i.e . insulin pump , drug infusion device ) Claustrophobia Metal shrapnel bullet Investigator assessment inability comply protocol Unable/unwilling lie still throughout research procedure require sedation Persons cognitive impairment</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 11, 2016</verification_date>
	<keyword>MRI</keyword>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Cardiac</keyword>
	<keyword>Myocardium</keyword>
	<keyword>Intramyocardial fat</keyword>
</DOC>